Breaking News Instant updates and real-time market news.

2023-03-01 06:58:26 RETA Reata Pharmaceuticals $31.11 / +0.23 (+0.74%) 06:58 03/01/23 03/01 06:58 03/01/23 06:58	Reata Pharmaceuticals price target raised to $85 from $40 at Baird Baird analyst Brian Skorney raised the firm's price target on Reata Pharmaceuticals to $85 from $40 and keeps a Neutral rating on the shares. The analyst said the approval of Skyclarys (omaveloxolone) ends some pretty dramatic debates and stock moves. With the regulatory decision in the rearview, focus now is on launch. The FDA label looks fairly clean and consistent with what is already known about omav's profile and with its addressable market, the U.S. opportunity could approach $1B.	01 Mar

2023-03-01 06:58:26

RETA

Reata Pharmaceuticals

$31.11 / +0.23 (+0.74%)

06:58

03/01/23

03/01

06:58

03/01/23

06:58

Reata Pharmaceuticals price target raised to $85 from $40 at Baird

Baird analyst Brian Skorney raised the firm's price target on Reata Pharmaceuticals to $85 from $40 and keeps a Neutral rating on the shares. The analyst said the approval of Skyclarys (omaveloxolone) ends some pretty dramatic debates and stock moves. With the regulatory decision in the rearview, focus now is on launch. The FDA label looks fairly clean and consistent with what is already known about omav's profile and with its addressable market, the U.S. opportunity could approach $1B.

01
Mar

OTHER BREAKING NEWS FROM THE FLY

Conference/Events	Zeta Global management to meet with B. Riley » 11:50 03/28/23 03/28 11:50 03/28/23 11:50 ZETA Zeta Global $10.44 / +0.085 (+0.82%) Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ZETA Zeta Global $10.44 / +0.085 (+0.82%) 02/24/23 Zeta Global rises 12.4% 02/24/23 Zeta Global rises 12.0% 11/30/22 Zeta Global announces record results for ZMP ZETA Zeta Global $10.44 / +0.085 (+0.82%) 02/24/23 Barclays Zeta Global price target raised to $11 from $10 at Barclays 12/09/22 B. Riley B. Riley starts 'well positioned' Zeta with Buy, $13 target 12/09/22 B. Riley Zeta Global initiated with a Buy at B. Riley 11/21/22 Credit Suisse Zeta Global initiated with a Neutral at Credit Suisse ZETA Zeta Global $10.44 / +0.085 (+0.82%) 02/23/23 Zeta Global announces long-term targets 02/23/23 Zeta Global sees FY23 revenue $686M-$696M, consensus $671.63M 02/23/23 Zeta Global sees Q1 revenue $149M-$151M, consensus $151.3M. 02/23/23 Zeta Global reports Q4 EPS (36c) vs. (46c) last year ZETA Zeta Global $10.44 / +0.085 (+0.82%) 02/24/23 What You Missed On Wall Street On Friday 02/24/23 What You Missed On Wall Street This Morning 03/30/23 Zeta Global 05/10/23 Zeta Global
Conference/Events	Arch Resources management to meet with B. Riley » 11:49 03/28/23 03/28 11:49 03/28/23 11:49 ARCH Arch Resources $134.04 / +1.71 (+1.29%) Meeting to be held in New… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ARCH Arch Resources $134.04 / +1.71 (+1.29%) 03/09/23 Arch Resources' AC5 system receives dedicated HCPCS billing code 02/16/23 Arch Resources sees FY23 sales volume 74.9M-$83.7M tons ARCH Arch Resources $134.04 / +1.71 (+1.29%) 03/14/23 BMO Capital Arch Resources coverage transferred with an Outperform rating at BMO Capital 02/17/23 BMO Capital Arch Resources price target raised to $200 from $185 at BMO Capital 02/17/23 B. Riley Arch Resources price target lowered to $204 from $207 at B. Riley 01/17/23 B. Riley Arch Resources price target lowered to $207 from $221 at B. Riley ARCH Arch Resources $134.04 / +1.71 (+1.29%) 02/16/23 Arch Resources reports Q4 EPS $23.18, consensus $12.54 10/27/22 Arch Resources reports Q3 EPS $8.68, consensus $9.61 ARCH Arch Resources $134.04 / +1.71 (+1.29%) 10/28/22 Short Report: Arch Resources results spoil bearish build-up 10:00 Today Metals & Mining 03/29/23 Arch Resources
Recommendations	Stifel reiterates Buy on Viking Therapeutics, raises price target to $25 » 11:47 03/28/23 03/28 11:47 03/28/23 11:47 VKTX Viking Therapeutics $14.13 / +5 (+54.76%) Stifel raised the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options VKTX Viking Therapeutics $14.13 / +5 (+54.76%) 07:05 Today Viking Therapeutics initiates Phase 1 study of novel formulation of VK2735 06:50 Today Viking Therapeutics jumps 32% to $12.06 after Phase 1 VK2735 trial results 06:41 Today Viking Therapeutics announces results from Phase 1 trial of VK2735 01/09/23 Viking Therapeutics completes enrollment in Phase 2b VOYAGE study of VK2809 VKTX Viking Therapeutics $14.13 / +5 (+54.76%) 11:02 Today H.C. Wainwright Viking's VK2735 looks like 'heavyweight contender,' says H.C. Wainwright 03/22/23 Stifel Stifel argues sympathy trading not a predictor for Viking's pending VK2735 data 03/21/23 William Blair William Blair says Viking bull thesis intact after Altimmune data 03/16/23 Stifel Viking Therapeutics initiated with a Buy at Stifel VKTX Viking Therapeutics $14.13 / +5 (+54.76%) 02/08/23 Viking Therapeutics reports Q4 EPS (26c), consensus (23c) 10/26/22 Viking Therapeutics reports Q3 EPS (21c), consensus (23c) VKTX Viking Therapeutics $14.13 / +5 (+54.76%) 01/02/23 Viking sued Ascletis alleging stolen trade secrets, Reuters reports VKTX Viking Therapeutics $14.13 / +5 (+54.76%) 12/21/22 Biotech Alert: Searches spiking for these stocks today 12/19/22 Trial success is rocketing this NASH stock higher and sinking these peers VKTX Viking Therapeutics $14.13 / +5 (+54.76%) 03/21/23 Viking Therapeutics call volume above normal and directionally bullish 03/16/23 Viking Therapeutics call volume above normal and directionally bullish 03/08/23 Viking Therapeutics call volume above normal and directionally bullish 02/17/23 Viking Therapeutics call volume above normal and directionally bullish
Conference/Events	JPMorgan SMid cap biotech analyst to hold analyst/industry conference call » 11:47 03/28/23 03/28 11:47 03/28/23 11:47 SMid Cap Biotech Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Puyi Inc (ADR) trading halted, volatility trading pause 11:44 03/28/23 03/28 11:44 03/28/23 11:44 PUYI Puyi $6.30 / -0.09 (-1.41%) ShowHide Related Items >><< Company News PUYI Puyi $6.30 / -0.09 (-1.41%) 03/01/23 Puyi Inc (ADR) trading resumes 03/01/23 Puyi Inc (ADR) trading halted, volatility trading pause
Syndicate	TMT Acquisition opens at $10.20, IPO priced at $10 per unit » 11:41 03/28/23 03/28 11:41 03/28/23 11:41 TMTC TMT Acquisition / + TMT Acquisition Corp… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Periodicals	Olaplex launching lash bond building serum, WWD reports » 11:38 03/28/23 03/28 11:38 03/28/23 11:38 OLPX Olaplex Holdings $4.06 / +0.065 (+1.63%) , ULTA Ulta Beauty $525.92 / +5.26 (+1.01%) Olaplex (OLPX) is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options OLPX ULTA OLPX Olaplex Holdings $4.06 / +0.065 (+1.63%) 10/19/22 Olaplex Holdings announces resignation of COO Tiffany Walden 10/02/22 Fly Intel: Top five weekend stock stories ULTA Ulta Beauty $525.92 / +5.26 (+1.01%) 03/09/23 Ulta Beauty sees operating margin at 14%-15% over next few years 02/05/23 Fly Intel: Top five weekend stock stories 12/05/22 Ulta Beauty CEO: Consumer is loving what we are offering 12/01/22 Ulta Beauty reports SSS up 14.6% y/y OLPX ULTA OLPX Olaplex Holdings $4.06 / +0.065 (+1.63%) 03/16/23 Piper Sandler Olaplex Holdings price target lowered to $4 from $5 at Piper Sandler 03/16/23 TD Cowen Olaplex Holdings downgraded at TD Cowen with turnaround seen needing time 03/16/23 TD Cowen Olaplex downgraded to Market Perform from Outperform at TD Cowen 03/03/23 Truist Olaplex Holdings price target raised to $15 from $10 at Truist ULTA Ulta Beauty $525.92 / +5.26 (+1.01%) 07:29 Today Canaccord Canaccord starts Ulta Beauty with a Buy, sees continued share gains 05:42 Today Canaccord Ulta Beauty initiated with a Buy at Canaccord 03/23/23 Piper Sandler Ulta Beauty price target raised to $615 from $610 at Piper Sandler 03/13/23 Morgan Stanley Ulta Beauty price target raised to $535 from $510 at Morgan Stanley OLPX ULTA OLPX Olaplex Holdings $4.06 / +0.065 (+1.63%) 02/28/23 Olaplex Holdings sees Q2 revenue up from Q1 but down significantly from 2Q22 02/28/23 Olaplex Holdings sees Q1 revenue growth (41%), consensus $179.17M 02/28/23 Olaplex Holdings sees FY23 revenue $563M-$634M, consensus $730.69M 02/28/23 Olaplex Holdings reports Q4 adjusted EPS 7c, consensus 6c ULTA Ulta Beauty $525.92 / +5.26 (+1.01%) 03/09/23 Ulta Beauty guides initial FY23 EPS $24.70-$25.40, consensus $24.25 03/09/23 Ulta Beauty reports Q4 EPS $6.68, consensus $5.66 03/09/23 Notable companies reporting after market close 12/01/22 Ulta Beauty raises FY22 EPS view to $22.60-$22.90 from $20.70-$21.20 OLPX ULTA OLPX Olaplex Holdings $4.06 / +0.065 (+1.63%) 03/03/23 Dozens of plaintiffs join Olaplex lawsuit over hair loss, Insider reports 12/14/22 Influencer warns followers Olaplex broke her hair, Bloomberg reports 10/01/22 Olaplex looks like a beauty of a bargain, Barron's says ULTA Ulta Beauty $525.92 / +5.26 (+1.01%) 02/04/23 Buy Ulta Beauty stock, a winner in good times and bad, Barron's says 01/12/23 Conagra doesn't see need for 'big' price hikes in 2023, WSJ says OLPX ULTA OLPX Olaplex Holdings $4.06 / +0.065 (+1.63%) 03/03/23 What You Missed On Wall Street This Morning 12/14/22 What You Missed On Wall Street On Wednesday 12/14/22 What You Missed On Wall Street This Morning 10/22/22 Buy/Sell: Wall Street's top 10 stock calls this week ULTA Ulta Beauty $525.92 / +5.26 (+1.01%) 09:55 Today Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/10/23 What You Missed On Wall Street On Friday 03/10/23 What You Missed On Wall Street This Morning 03/09/23 Fly Intel: After-Hours Movers 04/26/23 Ulta Beauty OLPX ULTA OLPX Olaplex Holdings $4.06 / +0.065 (+1.63%) 03/27/23 Unusually active option classes on open March 27th ULTA Ulta Beauty $525.92 / +5.26 (+1.01%) 03/09/23 Ulta Beauty options imply 4.9% move in share price post-earnings 12/01/22 Ulta Beauty options imply 5.0% move in share price post-earnings 10/11/22 Early notable gainers among liquid option names on October 11th
Hot Stocks	Apple introduces Apple Pay Later, consumers able to pay for purchases over time » 11:35 03/28/23 03/28 11:35 03/28/23 11:35 AAPL Apple $156.56 / -1.74 (-1.10%) , MA MasterCard $354.79 / +0.43 (+0.12%) , GS Goldman Sachs $318.47 / -0.12 (-0.04%) Apple (AAPL) introduced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AAPL MA GS AAPL Apple $156.56 / -1.74 (-1.10%) 10:35 Today Apple launches Apple Music Classical standalone app 03/24/23 Apple COO sells $30.0M in common stock 03/14/23 Apple launches Shop with a Specialist over Video 03/09/23 Apple says Apple Music Classical releases March 28 MA MasterCard $354.79 / +0.43 (+0.12%) 03/20/23 MasterCard acquires Baffin Bay Networks, terms undisclosed 03/07/23 GIACT partners with MasterCard to leverage Open Banking capabilities 02/21/23 MasterCard names Karen Griffin as chief risk officer 02/14/23 Tiger Global boosts stakes in Visa, Mastercard, reduces position in Microsoft GS Goldman Sachs $318.47 / -0.12 (-0.04%) 03/26/23 Fly Intel: Top five weekend stock stories 03/24/23 Ally Financial names Russell Hutchinson as CFO, effective July 3 03/19/23 Fly Intel: Top five weekend stock stories 03/16/23 First Republic confirms it will receive deposits totaling $30B from banks AAPL MA GS AAPL Apple $156.56 / -1.74 (-1.10%) 05:41 Today Barclays Apple advertising on own apps is underappreciated, says Barclays 03/21/23 Morgan Stanley Microsoft app store longer-term Apple risk 'worth watching,' says Morgan Stanley 03/16/23 Susquehanna Qualcomm upgraded at Susquehanna with China opening, Apple 'de-risked' 03/14/23 Evercore ISI Apple premium to big tech 'justified,' could expand further, says Evercore ISI MA MasterCard $354.79 / +0.43 (+0.12%) 02/01/23 BTIG CFPB credit card late fee proposal 'more onerous than expected,' says BTIG 01/30/23 Mizuho MasterCard price target raised to $405 from $380 at Mizuho 01/29/23 Barclays MasterCard price target raised to $437 from $427 at Barclays 01/27/23 Deutsche Bank MasterCard price target raised to $430 from $375 at Deutsche Bank GS Goldman Sachs $318.47 / -0.12 (-0.04%) 03/24/23 RBC Capital Goldman Sachs price target lowered to $339 from $370 at RBC Capital 03/09/23 BofA Goldman Sachs price target raised to $425 from $384 at BofA 03/02/23 Seaport Global Goldman remains a top pick at Seaport after investor day 03/01/23 Jefferies Jefferies keeps Buy on Goldman Sachs, says 'questions remain' after investor day AAPL MA GS AAPL Apple $156.56 / -1.74 (-1.10%) 02/02/23 Apple reports Q1 EPS $1.88, consensus $1.94 02/02/23 Notable companies reporting after market close 10/27/22 Apple reports Q4 EPS $1.29, consensus $1.17 10/27/22 Notable companies reporting after market close MA MasterCard $354.79 / +0.43 (+0.12%) 01/26/23 MasterCard sees FY23 revenue growth at high end of low double digit rate 01/26/23 MasterCard sees Q1 revenue growth at low end of low double digit rate 01/26/23 MasterCard reports Q4 adjusted EPS $2.65, consensus $2.58 01/25/23 Notable companies reporting before tomorrow's open GS Goldman Sachs $318.47 / -0.12 (-0.04%) 01/17/23 Goldman Sachs reports Q4 EPS $3.32, consensus $5.48 10/18/22 Goldman Sachs reports Q3 EPS $8.25, consensus $7.69 10/17/22 Notable companies reporting before tomorrow's open 10/17/22 Notable companies reporting before tomorrow's open AAPL MA GS AAPL Apple $156.56 / -1.74 (-1.10%) 03/27/23 Apple demos mixed reality headset for Top 100 executives, Bloomberg reports 03/24/23 Apple tracking employee attendance via badge records, says Platformer's Schiffer 03/23/23 Apple to spend $1B a year to produce theatrical releases, Bloomberg reports 03/23/23 Apple weighs bidding for English football streaming rights, Bloomberg reports MA MasterCard $354.79 / +0.43 (+0.12%) 12/10/22 Microsoft, Arista among stocks that can survive a triple whammy, Barron's says 11/27/22 Adobe says Black Friday online sales climb 2.3%, Bloomberg reports 10/17/22 FTC expands probe of Visa, MasterCard debit-card routing, WSJ says 10/04/22 MasterCard to launch Crypto Secure tool for combating fraud, CNBC reports GS Goldman Sachs $318.47 / -0.12 (-0.04%) 03/26/23 Banking stress puts U.S., Europe on watch for credit crunch, Reuters says 03/20/23 Goldman tells Reuters Credit Suisse AT1 move could cut long-term demand 03/20/23 Big-bank CEOs discussing capital infusion for First Republic, WSJ says 03/18/23 Biggest banks looking like winners, Barron's says AAPL MA GS AAPL Apple $156.56 / -1.74 (-1.10%) 03/27/23 What You Missed On Wall Street On Monday 03/27/23 What You Missed On Wall Street This Morning 03/24/23 What You Missed On Wall Street This Morning 03/21/23 What You Missed This Week in Video Games MA MasterCard $354.79 / +0.43 (+0.12%) 03/01/23 Here's what Wall Street experts are saying about Salesforce ahead of earnings 02/09/23 Here's what Wall St. experts are saying about PayPal ahead of earnings 01/26/23 What You Missed On Wall Street On Thursday 01/26/23 What You Missed On Wall Street This Morning GS Goldman Sachs $318.47 / -0.12 (-0.04%) 03/16/23 What You Missed On Wall Street This Morning 02/24/23 What You Missed On Wall Street On Friday 02/17/23 What You Missed On Wall Street On Friday 02/17/23 What You Missed On Wall Street This Morning 04/18/23 Goldman Sachs - GS 04/26/23 Goldman Sachs Group Inc. 06/27/23 MasterCard Inc. AAPL MA GS AAPL Apple $156.56 / -1.74 (-1.10%) 08:55 Today Notable open interest changes for March 28th 03/27/23 Notable open interest changes for March 27th 03/24/23 Notable open interest changes for March 24th 03/22/23 Notable open interest changes for March 22nd MA MasterCard $354.79 / +0.43 (+0.12%) 01/09/23 Unusually active option classes on open January 9th GS Goldman Sachs $318.47 / -0.12 (-0.04%) 03/09/23 World Low Volatility ETF put volume heavy and directionally bearish 01/17/23 Unusually active option classes on open January 17th 12/05/22 World Low Volatility ETF put volume heavy and directionally bearish 10/18/22 Unusually active option classes on open October 18th
Periodicals	Endeavor Group weighing sale of IMG Academy, Sportico reports » 11:35 03/28/23 03/28 11:35 03/28/23 11:35 EDR Endeavor Group $22.92 / +0.12 (+0.53%) Endeavor Group is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options EDR Endeavor Group $22.92 / +0.12 (+0.53%) 11/17/22 Endeavor CFO Lublin sells 46,510 class A shares 10/26/22 Endeavor Group's IMG sells The Miss Universe Organization to JKN EDR Endeavor Group $22.92 / +0.12 (+0.53%) 03/13/23 Deutsche Bank Endeavor one of the best positioned media companies, says Deutsche Bank 08/29/22 Credit Suisse Endeavor Group price target lowered to $33 from $40 at Credit Suisse 08/04/22 BofA BofA starts 'well positioned' Endeavor Group at Buy 08/04/22 BofA Endeavor Group initiated with a Buy at BofA EDR Endeavor Group $22.92 / +0.12 (+0.53%) 02/28/23 Endeavor Group sees Fy23 revenue $5.825B-$5.975B, consensus $5.81B 02/28/23 Endeavor Group reports Q4 EPS (72c) vs (7c) last year 11/10/22 Endeavor cuts FY22 revenue view to $5.235B-$5.325B, consensus $5.36B 11/10/22 Endeavor reports Q3 EPS (4c), consensus 29c EDR Endeavor Group $22.92 / +0.12 (+0.53%) 03/07/23 Endeavor made mid-January investment in Twitter, Axios reports 02/17/23 McMahon seeks as much as $9B in potential sale of WWE, Bloomberg says 01/12/23 Khans' All Elite Wrestling a potential WWE suitor, Barron's says 09/30/22 Twitter, Musk do not appear to be having serious settlement talks, CNBC says EDR Endeavor Group $22.92 / +0.12 (+0.53%) 03/08/23 #SocialStocks: FTC probes Twitter's communications and layoffs 03/07/23 What You Missed On Wall Street This Morning 11/10/22 Fly Intel: After-Hours Movers 10/05/22 #SocialStocks: Twitter and Musk now working towards closing original deal EDR Endeavor Group $22.92 / +0.12 (+0.53%) 02/06/23 Largest borrow rate increases among liquid names
Periodicals	Congress members claim Sony unfairly harming Xbox in Japan, Axios reports » 11:28 03/28/23 03/28 11:28 03/28/23 11:28 SONY Sony $86.14 / -0.46 (-0.53%) , MSFT Microsoft $273.00 / -3.33 (-1.21%) Eleven members of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SONY MSFT SONY Sony $86.14 / -0.46 (-0.53%) 03/24/23 CMA 'narrows scope of concerns' in Microsoft-Activision review 03/15/23 Bethesda's 'Ghostwire: Tokyo' launches April 12 on Xbox Series X/S 03/10/23 Sony says 'Hogwarts Legacy' most downloaded PS5 game in February 03/09/23 Capcom says 'Exoprimal' out July 14, 'Resident Evil 4' demo out now MSFT Microsoft $273.00 / -3.33 (-1.21%) 03/27/23 Microsoft, Internews, USAID to develop Media Viability Accelerator 03/24/23 CMA 'narrows scope of concerns' in Microsoft-Activision review 03/22/23 Microsoft, CarbonCapture reach carbon removal credits agreement 03/22/23 Syneos Health and KX team on predictive analytics, AI and ML SONY MSFT SONY Sony $86.14 / -0.46 (-0.53%) 02/03/23 Cowen Sony price target raised to $118 from $102 at Cowen 11/02/22 Cowen Sony price target lowered to $102 from $144 at Cowen 10/13/22 Oppenheimer Oppenheimer sees more difficulty for Microsoft/Activision to win CMA approval 09/07/22 Goldman Sachs Sony resumed with a Neutral at Goldman Sachs MSFT Microsoft $273.00 / -3.33 (-1.21%) 07:03 Today BMO Capital Microsoft price target raised to $305 from $265 at BMO Capital 03/26/23 Citi Activision Blizzard price target raised to $91 from $88 at Citi 03/21/23 Morgan Stanley Microsoft app store longer-term Apple risk 'worth watching,' says Morgan Stanley 03/20/23 Stifel Alphabet resumed with a Buy at Stifel SONY MSFT SONY Sony $86.14 / -0.46 (-0.53%) 02/02/23 Sony raises FY net income view to Y870B from Y840B 02/02/23 Sony reports nine months EPS Y654.41 vs. Y622.03 last year 11/01/22 Sony raises FY revenue view to Y11.6T from Y11.5T 11/01/22 Sony reports Q2 revenue Y2.752T vs. Y2.369T last year MSFT Microsoft $273.00 / -3.33 (-1.21%) 01/24/23 Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29 01/24/23 Notable companies reporting after market close 10/25/22 Microsoft sees FX decreasing total revenue growth by 5% in FY23 10/25/22 Microsoft reports Q1 EPS $2.35, consensus $2.30 SONY MSFT SONY Sony $86.14 / -0.46 (-0.53%) 03/22/23 Microsoft says a decade enough time for Sony to make 'COD' alternative, VGC says 03/21/23 'WWE 2K23' passes 'Hogwarts Legacy' in U.K. boxed charts, GI.biz reports 03/20/23 Microsoft's EU remedies focus only on cloud gaming services, Reuters says 03/16/23 Sony says Xbox Game Pass 'far ahead' of PlayStation Plus, Verge reports MSFT Microsoft $273.00 / -3.33 (-1.21%) 11:19 Today Microsoft, OVH near settlement on EU antitrust complaints, Bloomberg says 05:31 Today Microsoft's GitHub cuts engineering team in India, TechCrunch reports 03/27/23 Microsoft tells Verge it no longer offers $1 Game Pass trial 03/27/23 Microsoft threatens to cut rivals' Bing search index access, Bloomberg reports SONY MSFT SONY Sony $86.14 / -0.46 (-0.53%) 03/26/23 Box Office Battle: ‘John Wick: Chapter 4’ opens with huge $73.5M 03/21/23 What You Missed This Week in Video Games 03/19/23 Box Office Battle: ‘Shazam 2’ opens with underwhelming $30.5M 03/14/23 What You Missed This Week in Video Games MSFT Microsoft $273.00 / -3.33 (-1.21%) 03/27/23 What You Missed On Wall Street On Monday 03/27/23 What You Missed On Wall Street This Morning 03/24/23 What You Missed On Wall Street On Friday 03/24/23 What You Missed On Wall Street This Morning 04/17/23 Software & Internet 04/24/23 RSA Conference 2023 SONY MSFT SONY Sony $86.14 / -0.46 (-0.53%) 09/30/22 Largest borrow rate increases among liquid names MSFT Microsoft $273.00 / -3.33 (-1.21%) 03/17/23 Early notable gainers among liquid option names on March 17th 03/17/23 Unusually active option classes on open March 17th 03/07/23 Microsoft put buyer realizes 3% same-day gains 02/13/23 Early notable gainers among liquid option names on February 13th

Options	Shift4 Payments call volume above normal and directionally bullish » 11:25 03/28/23 03/28 11:25 03/28/23 11:25 FOUR Shift4 Payments $68.02 / +0.94 (+1.40%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options FOUR Shift4 Payments $68.02 / +0.94 (+1.40%) 02/28/23 Shift4 Payments rises 9.1% 01/17/23 Shift4 Payments partners with Real Salt Lake 11/22/22 Shift4 Payments falls -8.5% 11/07/22 Shift4 Payments rises 10.6% FOUR Shift4 Payments $68.02 / +0.94 (+1.40%) 03/16/23 Truist Shift4 Payments price target raised to $87 from $80 at Truist 03/01/23 RBC Capital Shift4 Payments price target raised to $80 from $70 at RBC Capital 03/01/23 Piper Sandler Shift4 Payments price target raised to $85 from $69 at Piper Sandler 03/01/23 DA Davidson Shift4 Payments price target raised to $80 from $65 at DA Davidson FOUR Shift4 Payments $68.02 / +0.94 (+1.40%) 02/28/23 Shift4 Payments sees FY23 revenue $2.5B-$2.7B. consensus $2.74B 02/28/23 Shift4 Payments reports Q4 adjusted EPS 47c, consensus 38c 02/27/23 Notable companies reporting before tomorrow's open 02/27/23 Notable companies reporting before tomorrow's open FOUR Shift4 Payments $68.02 / +0.94 (+1.40%) 02/28/23 Fly Intel: Pre-market Movers 12/30/22 Buy/Sell: Wall Street's top 5 stock calls this week 12/29/22 What You Missed On Wall Street On Thursday 12/29/22 What You Missed On Wall Street This Morning FOUR Shift4 Payments $68.02 / +0.94 (+1.40%) 03/03/23 Shift4 Payments put volume heavy and directionally bearish 03/01/23 Shift4 Payments call volume above normal and directionally bullish
Conference/Events	Vaxart to host conference call » 11:24 03/28/23 03/28 11:24 03/28/23 11:24 VXRT Vaxart / + Key Opinion Leader Dr.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options VXRT Vaxart / + 03/17/23 Vaxart to host KOL webcast on health, economic impact for norovirus 02/14/23 Vaxart doses first subject in Phase 2 trial of bivalent norovirus candidate 12/19/22 Vaxart names Phillip Lee as Chief Financial Officer 12/01/22 Vaxart announces collaborative funding for study on Novovirus vaccine candidate VXRT Vaxart / + 12/19/22 B. Riley Vaxart price target lowered to $1.50 from $6 at B. Riley 09/02/22 Cantor Fitzgerald Vaxart price target lowered to $8 from $11 at Cantor Fitzgerald 05/19/22 B. Riley Vaxart price target lowered to $6 from $7 at B. Riley VXRT Vaxart / + 11/08/22 Vaxart reports Q3 EPS (23c), consensus (24c) VXRT Vaxart / + 03/07/23 Vaxart options imply 40.1% move in share price post-earnings 03/06/23 Vaxart options imply 39.1% move in share price post-earnings
Recommendations	MAG Silver price target lowered to C$25.75 from C$27.75 at Stifel » 11:20 03/28/23 03/28 11:20 03/28/23 11:20 MAG MAG Silver $11.99 / -0.09 (-0.75%) Stifel analyst Stephen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MAG MAG Silver $11.99 / -0.09 (-0.75%) 02/07/23 MAG Silver closes $42.6M common share offering 01/25/23 MAG reports Q4 production at Juanicipio 165,786 tonnes of mineralized material 12/28/22 MAG Silver says final testing of control systems at Juanicipio Project complete 10/26/22 MAG Silver reports Q3 production 2,617,146 silver ounces and 5,422 gold ounces MAG MAG Silver $11.99 / -0.09 (-0.75%) 11:05 Today Raymond James MAG Silver price target lowered to C$25 at Raymond James 10:26 Today CIBC MAG Silver price target lowered to C$21 from C$24 at CIBC 06:11 Today H.C. Wainwright MAG Silver price target lowered to $16 from $17 at H.C. Wainwright 02/17/23 Canaccord MAG Silver price target lowered to C$26 from C$27 at Canaccord MAG MAG Silver $11.99 / -0.09 (-0.75%) 03/27/23 MAG Silver reports Q4 EPS (1c) vs. 9c last year
Periodicals	Microsoft, OVH near settlement on EU antitrust complaints, Bloomberg says » 11:19 03/28/23 03/28 11:19 03/28/23 11:19 MSFT Microsoft $272.63 / -3.7 (-1.34%) Microsoft is nearing a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MSFT Microsoft $272.63 / -3.7 (-1.34%) 03/27/23 Microsoft, Internews, USAID to develop Media Viability Accelerator 03/24/23 CMA 'narrows scope of concerns' in Microsoft-Activision review 03/22/23 Microsoft, CarbonCapture reach carbon removal credits agreement 03/22/23 Syneos Health and KX team on predictive analytics, AI and ML MSFT Microsoft $272.63 / -3.7 (-1.34%) 07:03 Today BMO Capital Microsoft price target raised to $305 from $265 at BMO Capital 03/26/23 Citi Activision Blizzard price target raised to $91 from $88 at Citi 03/21/23 Morgan Stanley Microsoft app store longer-term Apple risk 'worth watching,' says Morgan Stanley 03/20/23 Stifel Alphabet resumed with a Buy at Stifel MSFT Microsoft $272.63 / -3.7 (-1.34%) 01/24/23 Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29 01/24/23 Notable companies reporting after market close 10/25/22 Microsoft sees FX decreasing total revenue growth by 5% in FY23 10/25/22 Microsoft reports Q1 EPS $2.35, consensus $2.30 MSFT Microsoft $272.63 / -3.7 (-1.34%) 05:31 Today Microsoft's GitHub cuts engineering team in India, TechCrunch reports 03/27/23 Microsoft tells Verge it no longer offers $1 Game Pass trial 03/27/23 Microsoft threatens to cut rivals' Bing search index access, Bloomberg reports 03/22/23 Microsoft launches preview of Microsoft Loop, Verge reports MSFT Microsoft $272.63 / -3.7 (-1.34%) 03/27/23 What You Missed On Wall Street On Monday 03/27/23 What You Missed On Wall Street This Morning 03/24/23 What You Missed On Wall Street On Friday 03/24/23 What You Missed On Wall Street This Morning 04/17/23 Software & Internet 04/24/23 RSA Conference 2023 MSFT Microsoft $272.63 / -3.7 (-1.34%) 03/17/23 Early notable gainers among liquid option names on March 17th 03/17/23 Unusually active option classes on open March 17th 03/07/23 Microsoft put buyer realizes 3% same-day gains 02/13/23 Early notable gainers among liquid option names on February 13th
Recommendations	Copper Mountain Mining price target raised to C$2.20 from C$2 at Stifel » 11:19 03/28/23 03/28 11:19 03/28/23 11:19 CPPMF Copper Mountain Mining $1.48 / +0.164 (+12.46%) Stifel analyst Alex… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research CPPMF Copper Mountain Mining $1.48 / +0.164 (+12.46%) 11/28/22 Copper Mountain receives bondholder approval for sale of Eva Copper project CPPMF Copper Mountain Mining $1.48 / +0.164 (+12.46%) 10:57 Today BMO Capital Copper Mountain price target lowered to C$2.25 from C$2.50 at BMO Capital 07:05 Today BMO Capital Copper Mountain Mining price target lowered to $2.25 from $2.50 at BMO Capital 02/13/23 National Bank Copper Mountain price target raised to C$2.50 from C$2.25 at National Bank 02/07/23 Scotiabank Copper Mountain Mining price target lowered to C$2.75 from C$3 at Scotiabank
Technical Analysis	NASDAQ market internals summary » 11:17 03/28/23 03/28 11:17 03/28/23 11:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 10:17 Today NASDAQ market internals summary 03/27/23 NASDAQ market internals summary 03/27/23 NASDAQ market internals summary 03/27/23 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 11:16 03/28/23 03/28 11:16 03/28/23 11:16 $NYE NYSE Market Internals / + Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 10:16 Today NYSE market internals summary 03/27/23 NYSE market internals summary 03/27/23 NYSE market internals summary 03/27/23 NYSE market internals summary
Hot Stocks	Harmony Biosciences 'disagrees' with Scorpion Capital's 'assertions' » 11:15 03/28/23 03/28 11:15 03/28/23 11:15 HRMY Harmony Biosciences $32.81 / -8.69 (-20.94%) In a statement emailed to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly HRMY Harmony Biosciences $32.81 / -8.69 (-20.94%) 01/09/23 Novavax names John Jacobs as new CEO, succeeding Stanley Erck 01/06/23 Harmony Biosciences CEO John Jacobs stepping down 11/15/22 Harmony Biosciences director sells $9.12M in common stock 11/01/22 Harmony Biosciences reports topline Phase 2 results of pitolisant HRMY Harmony Biosciences $32.81 / -8.69 (-20.94%) 02/22/23 Mizuho Harmony Biosciences price target lowered to $60 from $70 at Mizuho 01/04/23 Piper Sandler Harmony Biosciences price target raised to $70 from $62 at Piper Sandler 11/08/22 Mizuho Harmony Biosciences price target raised to $70 from $60 at Mizuho 10/14/22 Jefferies Jefferies upgrades 'undervalued' Harmony Biosciences to Buy HRMY Harmony Biosciences $32.81 / -8.69 (-20.94%) 02/21/23 Harmony Biosciences reports Q4 non-GAAP EPS $1.01, consensus 58c 11/01/22 Harmony Biosciences reports Q3 non-GAAP EPS 95c vs 41c last year HRMY Harmony Biosciences $32.81 / -8.69 (-20.94%) 09:47 Today Scorpion: Filing Citizen's Petition to request withdrawal of Harmony drug 09:47 Today Scorpion Capital issues investigative report on Harmony Biosciences HRMY Harmony Biosciences $32.81 / -8.69 (-20.94%) 10:20 Today Harmony plunges as Scorpion seeks FDA withdrawal of Wakix approval 10/14/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Options	Ares Capital put volume heavy and directionally bearish » 11:15 03/28/23 03/28 11:15 03/28/23 11:15 ARCC Ares Capital $17.76 / -0.075 (-0.42%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options ARCC Ares Capital $17.76 / -0.075 (-0.42%) 01/19/23 Ares Capital names Jana Markowicz as Chief Operating Officer ARCC Ares Capital $17.76 / -0.075 (-0.42%) 10/27/22 Citi Ares Capital price target lowered to $21 from $24 at Citi 04/27/22 JPMorgan Ares Capital upgraded to Overweight from Neutral at JPMorgan 04/27/22 Hovde Group Ares Capital upgraded to Outperform from Market Perform at Hovde Group ARCC Ares Capital $17.76 / -0.075 (-0.42%) 02/07/23 Ares Capital reports Q4 core EPS 63c, consensus 56c 10/25/22 Ares Capital reports Q4 EPS 50c, consensus 49c 13 Jan 08 Nov 29 Jul ARCC Ares Capital $17.76 / -0.075 (-0.42%) 01/12/23 Fly Intel: After-Hours Movers 05/17/23 Ares Capital Corporation ARCC Ares Capital $17.76 / -0.075 (-0.42%) 09:40 Today Unusually active option classes on open March 28th 03/23/23 Ares Capital put volume heavy and directionally bearish 03/13/23 Ares Capital put volume heavy and directionally bearish 03/10/23 Ares Capital put volume heavy and directionally bearish
Syndicate	Jin Medical opens at $8, IPO priced at $8 per share » 11:11 03/28/23 03/28 11:11 03/28/23 11:11 ZJYL Jin Medical / + Jin Medical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Syndicate 28 Mar

Recommendations	MAG Silver price target lowered to C$25 at Raymond James » 11:05 03/28/23 03/28 11:05 03/28/23 11:05 MAG MAG Silver $11.99 / -0.09 (-0.75%) Raymond James lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MAG MAG Silver $11.99 / -0.09 (-0.75%) 02/07/23 MAG Silver closes $42.6M common share offering 01/25/23 MAG reports Q4 production at Juanicipio 165,786 tonnes of mineralized material 12/28/22 MAG Silver says final testing of control systems at Juanicipio Project complete 10/26/22 MAG Silver reports Q3 production 2,617,146 silver ounces and 5,422 gold ounces MAG MAG Silver $11.99 / -0.09 (-0.75%) 10:26 Today CIBC MAG Silver price target lowered to C$21 from C$24 at CIBC 06:11 Today H.C. Wainwright MAG Silver price target lowered to $16 from $17 at H.C. Wainwright 02/17/23 Canaccord MAG Silver price target lowered to C$26 from C$27 at Canaccord 02/08/23 Raymond James MAG Silver price target raised to C$25.50 from C$24.50 at Raymond James MAG MAG Silver $11.99 / -0.09 (-0.75%) 03/27/23 MAG Silver reports Q4 EPS (1c) vs. 9c last year
Options	Aurinia Pharmaceuticals call volume above normal and directionally bullish » 11:05 03/28/23 03/28 11:05 03/28/23 11:05 AUPH Aurinia Pharmaceuticals $11.56 / +0.745 (+6.89%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AUPH Aurinia Pharmaceuticals $11.56 / +0.745 (+6.89%) 01/25/23 Aurinia says PTAB has terminated Inter Partes review 01/24/23 Aurinia announces allowance of new, refined method of use patent for LUPKYNIS 01/03/23 Aurinia Pharmaceuticals enters patent settlement pact with Sun Pharmaceutical 11/30/22 Aurinia announces U.K. marketing authorization of Lupkynis AUPH Aurinia Pharmaceuticals $11.56 / +0.745 (+6.89%) 01/03/23 RBC Capital Aurinia price target raised to $11 from $10 at RBC Capital 11/07/22 H.C. Wainwright Aurinia Pharmaceuticals price target lowered to $14 from $26 at H.C. Wainwright 11/04/22 Oppenheimer Oppenheimer downgrades Aurinia on commercial challenges 11/04/22 Oppenheimer Aurinia Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer AUPH Aurinia Pharmaceuticals $11.56 / +0.745 (+6.89%) 02/28/23 Aurinia Pharmaceuticals reports Q4 EPS (18c), consensus (27c) 01/06/23 Aurinia Pharmaceuticals backs FY23 net product revenue view $120M-$140M 01/06/23 Aurinia Pharmaceuticals reports preliminary net FY22 revenue $134M 01/06/23 Aurinia Pharmaceuticals reports preliminary Q4 revenue $28.4M, consensus $26.97M AUPH Aurinia Pharmaceuticals $11.56 / +0.745 (+6.89%) 03/23/23 Aurinia Pharmaceuticals rumor highlighted by Betaville blog 01/04/23 Aurinia worth 'keeping closer eye on' after settlement, Dealreporter says AUPH Aurinia Pharmaceuticals $11.56 / +0.745 (+6.89%) 01/06/23 What You Missed On Wall Street On Friday 01/06/23 What You Missed On Wall Street This Morning 01/06/23 Fly Intel: Pre-market Movers 01/05/23 Biotech Alert: Searches spiking for these stocks today AUPH Aurinia Pharmaceuticals $11.56 / +0.745 (+6.89%) 03/24/23 Aurinia Pharmaceuticals call volume above normal and directionally bullish 03/08/23 Aurinia Pharmaceuticals call volume above normal and directionally bullish 03/06/23 Aurinia Pharmaceuticals call volume above normal and directionally bullish 01/25/23 Aurinia Pharmaceuticals call volume above normal and directionally bullish
Recommendations	BRP Inc. price target raised to C$138 from C$137 at RBC Capital » 11:04 03/28/23 03/28 11:04 03/28/23 11:04 DOOO BRP Inc. $74.58 / -1.24 (-1.64%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly DOOO BRP Inc. $74.58 / -1.24 (-1.64%) 01/20/23 BRP Inc. to begin construction of new boat manufacturing plant in Mexico 11/30/22 TSX approves BRP's renewal of its NCIB 10/04/22 BRP Inc. breaks ground on new Can-Am electric motorcycles plant DOOO BRP Inc. $74.58 / -1.24 (-1.64%) 03/24/23 Scotiabank BRP Inc. price target raised to C$149 from C$143 at Scotiabank 03/24/23 TD Securities BRP Inc. price target raised to C$135 from C$125 at TD Securities 03/24/23 Stifel BRP Inc. price target raised to C$150 from C$145 at Stifel 03/24/23 National Bank BRP Inc. price target raised to C$143 from C$139 at National Bank DOOO BRP Inc. $74.58 / -1.24 (-1.64%) 03/23/23 BRP Inc. sees FY24 normalized EPS C$12.25-C$12.75 03/23/23 BRP Inc. reports Q4 normalized EPS C$3.85 vs. C$3.00 last year DOOO BRP Inc. $74.58 / -1.24 (-1.64%) 03/23/23 Fly Intel: Pre-market Movers
Recommendations	Viking's VK2735 looks like 'heavyweight contender,' says H.C. Wainwright » 11:02 03/28/23 03/28 11:02 03/28/23 11:02 VKTX Viking Therapeutics $14.27 / +5.14 (+56.30%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options VKTX Viking Therapeutics $14.27 / +5.14 (+56.30%) 07:05 Today Viking Therapeutics initiates Phase 1 study of novel formulation of VK2735 06:50 Today Viking Therapeutics jumps 32% to $12.06 after Phase 1 VK2735 trial results 06:41 Today Viking Therapeutics announces results from Phase 1 trial of VK2735 01/09/23 Viking Therapeutics completes enrollment in Phase 2b VOYAGE study of VK2809 VKTX Viking Therapeutics $14.27 / +5.14 (+56.30%) 03/22/23 Stifel Stifel argues sympathy trading not a predictor for Viking's pending VK2735 data 03/21/23 William Blair William Blair says Viking bull thesis intact after Altimmune data 03/16/23 Stifel Viking Therapeutics initiated with a Buy at Stifel 02/23/23 Oppenheimer Viking Therapeutics price target raised to $20 from $17 at Oppenheimer VKTX Viking Therapeutics $14.27 / +5.14 (+56.30%) 02/08/23 Viking Therapeutics reports Q4 EPS (26c), consensus (23c) 10/26/22 Viking Therapeutics reports Q3 EPS (21c), consensus (23c) VKTX Viking Therapeutics $14.27 / +5.14 (+56.30%) 01/02/23 Viking sued Ascletis alleging stolen trade secrets, Reuters reports VKTX Viking Therapeutics $14.27 / +5.14 (+56.30%) 12/21/22 Biotech Alert: Searches spiking for these stocks today 12/19/22 Trial success is rocketing this NASH stock higher and sinking these peers VKTX Viking Therapeutics $14.27 / +5.14 (+56.30%) 03/21/23 Viking Therapeutics call volume above normal and directionally bullish 03/16/23 Viking Therapeutics call volume above normal and directionally bullish 03/08/23 Viking Therapeutics call volume above normal and directionally bullish 02/17/23 Viking Therapeutics call volume above normal and directionally bullish
Recommendations	Copper Mountain price target lowered to C$2.25 from C$2.50 at BMO Capital » 10:57 03/28/23 03/28 10:57 03/28/23 10:57 CPPMF Copper Mountain Mining $1.48 / +0.164 (+12.46%) BMO Capital lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research CPPMF Copper Mountain Mining $1.48 / +0.164 (+12.46%) 11/28/22 Copper Mountain receives bondholder approval for sale of Eva Copper project CPPMF Copper Mountain Mining $1.48 / +0.164 (+12.46%) 07:05 Today BMO Capital Copper Mountain Mining price target lowered to $2.25 from $2.50 at BMO Capital 02/13/23 National Bank Copper Mountain price target raised to C$2.50 from C$2.25 at National Bank 02/07/23 Scotiabank Copper Mountain Mining price target lowered to C$2.75 from C$3 at Scotiabank 01/09/23 National Bank Copper Mountain price target lowered to C$2.25 from C$2.75 at National Bank

Events

Earnings calls, analyst events, roadshows and more

Today at 12:00

Jim Cramer Monthly Meeting: March 2023 Government Event

Webcast
Today at 12:00

SMid Cap Biotech Industry Meetings
Today at 13:00

5-Year Note Auction Government Event
Today at 13:00

Money Supply: M2 - M/M: February 2023 Government Event
Today at 13:00

FY2024 Request for the Commodity Futures Trading Commission Government Event

2362-A Rayburn House Office Building, Washington, D.C.
VXRT
Today at 13:00

Vaxart - VXRT Conference Calls
Today at 13:00

Healthcare Policy Industry Meetings
CRVS
Today at 16:30

Corvus Pharmaceuticals - CRVS Conference Calls
LULU
Today at 16:30

Lululemon - LULU Conference Calls
IDEX
Today at 16:30

Ideanomics - IDEX Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Reata Pharmaceuticals price target raised to $85 from $40 at Baird

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access